Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 50,000 shares at $72.86 ($3.6M) on 2019-08-06, disclosed to the SEC on 2019-08-07.
Scheduled sale ($3.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.22 | 22,529 | $1.6M | 44.7% |
| 2 | $71.85 | 2,471 | $178K | 4.9% |
| 3 | $72.14 | 16,860 | $1.2M | 33.9% |
| 4 | $72.86 | 8,140 | $593K | 16.5% |
| Total | $71.83 avg | 50,000 | $3.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |
| GHDX | SELL | 2019-06-13 | $5.1M | — | Filing → |